Host Genetic Variants in the Interleukin-6 Promoter Predict Poor Outcome in Patients with Estrogen Receptor-Positive, Node-Positive Breast Cancer

Por DeMichele, Angela, Gray, Robert, Horn, Michelle, Chen, Jinbo, Aplenc, Richard, Vaughan, William P., Tallman, Martin S.
Publicado no Cancer Res (2009)

Association of cyclophosphamide drug metabolizing enzyme polymorphisms and chemotherapy related ovarian failure in breast cancer survivors

Por Su, H. Irene, Sammel, Mary D., Velders, Luke, Horn, Michelle, Stankiewicz, Corrie, Matro, Jennifer, Gracia, Clarisa R., Green, Jamie, DeMichele, Angela
Publicado em 2009

Cyclophosphamide- metabolizing enzyme polymorphisms and survival outcomes after adjuvant chemotherapy for node-positive breast cancer: a retrospective cohort study

Por Gor, Priya P, Su, H Irene, Gray, Robert J, Gimotty, Phyllis A, Horn, Michelle, Aplenc, Richard, Vaughan, William P, Tallman, Martin S, Rebbeck, Timothy R, DeMichele, Angela
Publicado em 2010

Concordance of copy number alterations using a common analytic pipeline for genome-wide analysis of Illumina and Affymetrix genotyping data: A report from the Children’s Oncology G...

Por Vujkovic, Marijana, Attiyeh, Edward F., Ries, Rhonda E., Horn, Michelle, Goodman, Elizabeth K., Ding, Yang, Kavcic, Marko, Alonzo, Todd A., Gerbing, Robert B., Hirsch, Betsy, Raimondi, Susana, Gamis, Alan S., Meshinchi, Soheil, Aplenc, Richard
Publicado no Cancer Genet (2015)